AMRN — AMARIN CORP PLC\UK

—
Nasdaq · Health Care · Pharmaceuticals · CIK 897448 · Ireland
Last close
$11.27
Market Cap
$473.82M
52W High
$17.31
52W Low
$11.15
ADV30
76,983
Next earnings
2026-10-28

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 39,550,000 16,181,000 -2,360,000 245,000 634,081,000 156,512,000 189,669,000
Jun 2026 42,211,000 14,989,000 -11,970,000 -7,650,000 624,363,000 143,558,000 180,747,000
Mar 2026 45,132,000 17,769,000 -8,011,000 -10,512,000 645,764,000 131,063,000 196,351,000
Dec 2025 49,219,000 23,169,000 -2,261,000 -1,224,000 670,775,000 134,660,000 211,494,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$37,493,000
Investing CF
$-1,119,000
Financing CF
$-2,764,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.00
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,725,261,000
Inventory
$158,850,000
Receivables
$111,573,000
ST Investments
$166,867,000
EBIT TTM
$-46,702,000
Pretax Income TTM
$-17,129,000
Interest Exp TTM
—
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$176,112,000
EBITDA
$-21,986,000
Free Cash Flow
$39,855,376
Enterprise Value
$-60,571,076
Total Cash
$323,379,008
Total Debt
$7,611,000
Shares Out
42,042,348
Trailing EPS
$-0.80
Book Value
$21.08
ROE
-4.2%
ROA
-2.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 213,646,000 -13,941,000 -38,798,000 670,775,000 211,494,000 459,281,000 6,728,000
Dec 2024 228,614,000 -91,797,000 -82,183,000 685,349,000 199,173,000 486,176,000 -31,020,000
Dec 2023 306,911,000 -56,616,000 -59,112,000 831,684,000 279,587,000 552,097,000 6,880,000
Dec 2022 369,193,000 -92,343,000 -105,803,000 886,179,000 290,846,000 595,333,000 -180,092,000

TTM Snapshot

Revenues TTM
$186,231,000
NetIncome TTM
$-27,124,000
OpCashFlow TTM
—
Assets (Latest)
$624,363,000
Forward EPS
$0.98

Peers — same industry

TickerNameMarket CapLastDaily %
KMDA KAMADA LTD $470.92M $8.16 —
NGNE Neurogene Inc. $478.19M $23.10 —
STTK Shattuck Labs, Inc. $467.46M $4.59 —
IMMP IMMUTEP Ltd $480.43M $3.26 —
BLSM BlossomHill Therapeutics, Inc. $480.91M $15.13 —

News headlines (Yahoo Finance, 1h cache)

Amarin: 3 Key Takeaways for Long-Term Investors
2026-11-11 22:35 · Yahoo
Amarin Highlights New Data on Lipoprotein(a) and other Apolipoprotein B Containing Lipoproteins at American Heart Association (AHA) Scientific Sessions 2026
2026-11-09 13:00 · Yahoo
Amarin (AMRN) Q3 Results Recast Profit Story As Revenue Falls
2026-10-30 01:14 · Yahoo
Amarin's Q3 Earnings Beat Estimates, Revenues Miss Mark
2026-10-29 15:31 · Yahoo
Amarin: Q3 Earnings Snapshot
2026-10-28 18:36 · Yahoo
Amarin (AMRN) Q3 2026 Earnings Call Transcript
2026-10-28 16:42 · Yahoo
Amarin Returns to Quarterly Profit as Cost Reductions Offset 20% Revenue Decline
2026-10-28 16:02 · Yahoo
What Amarin (AMRN) Said on Its Q3 Earnings Call
2026-10-28 14:04 · Yahoo
Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
2026-10-28 11:00 · Yahoo
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patien
2026-10-25 12:11 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.